16 Results for "

Cdc2-like kinases

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "Cdc2-like kinases" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-112296
CAS No.: 2407433-00-3
Purity:  99.64%
Target:  

CDK Apoptosis DYRK

Research Areas:  

Cancer

T025 is an orally active and highly potent inhibitor of Cdc2-like kinase (CLKs), with Kd values of 4.8, 0.096, 6.5, 0.61, 0.074, 1.5 and 32 nM for CLK1, CLK2, CLK3, CLK4, DYRK1A, DYRK1B and DYRK2, respectively. T025 induces caspase-3/7-mediated cell apoptosis. T025 reduces CLK-dependent phosphorylation. T025 exerts anti-proliferative activities in both hematological and solid cancer cell lines (IC50 values: 30-300 nM). T025 has an anti-tumor efficiency, mainly for MYC-driven disease research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103082
CAS No.: 2123491-32-5
Purity:  98.55%
Target:  

CDK

Research Areas:  

Others

CLK1-IN-1 is a potent and selective of Cdc2-like kinase 1 (CLK1) inhibitor, with an IC50 of 2 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12828
CAS No.: 1354037-26-5
Purity:  98.03%
Target:  

CDK

Research Areas:  

Infection Neurological Disease

KH-CB19 is a potent CLK (cdc2-like kinase) inhibitor (CLK1 IC50=19.7 nM; CLK3 IC50=530 nM). KH-CB19 shows antiviral activity and inhibits influenza virus replication (IC50=13.6?μM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108709
CAS No.: 1618658-88-0
Purity:  99.06%
Target:  

CDK

Research Areas:  

Cancer

CC-671 is a dual TTK protein kinase/CDC2-like kinase (CLK2) inhibitor with IC50s of 0.005 and 0.006 μM for TTK and CLK2, respectively.
loading...
    loading...
Cat. No.: HY-144875
CAS No.: 2144751-78-8
Purity:  98.15%
Synonyms: CTX-712
Target:  

CDK

Research Areas:  

Cancer

Rogocekib is an orally effective CLK 2 inhibitor, with an IC50 of 1.4 nM, showing anti-tumor activity .
loading...
    loading...
Cat. No.: HY-15951
CAS No.: 1285702-20-6
Synonyms: CID44968231; NCGC00188654
Target:  

CDK DYRK

Research Areas:  

Cancer

ML167 is a highly selective Cdc2-like kinase 4 (Clk4) inhibitor with IC50 of 136 nM, >10-fold selectivity for closely related kinases Clk1, Clk2, Clk3 and Dyrk1A/1B .
loading...
    loading...
Cat. No.: HY-103647
CAS No.: 443798-47-8
Purity:  98.08%
Target:  

CDK VEGFR GSK-3

Research Areas:  

Cancer

K00546 is a potent CDK1 and CDK2 inhibitor with IC50s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. K00546 is also a potent CDC2-like kinase 1 (CLK1) and CLK3 inhibitor with IC50s of 8.9 nM and 29.2 nM, respectively .
loading...
    loading...
Cat. No.: HY-131978
CAS No.: 2587177-94-2
Purity:  98.27%
Target:  

CDK

Research Areas:  

Cancer

DB18 is a potent and selective inhibitor of CDC2-like kinases (CLKs), with IC50 values in the range of 10-30 nM for CLK1, CLK2 and CLK4. DB18 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-153708
CAS No.: 748142-15-6
Purity:  99.12%
Synonyms: CAF-170
Target:  

CDK

Research Areas:  

Cancer

SGC-CLK-1, a chemical probe, is a potent and selective inhibitor of Cdc2-like kinases CLK1, CLK2, and CLK4. SGC-CLK-1 can inhibit the growth of melanoma and glioblastoma cells .
loading...
    loading...
Cat. No.: HY-162398
CAS No.: 2997615-62-8
Target:  

CDK

Research Areas:  

Inflammation/Immunology

LQ23 is a selective inhibitor for CDC2-like kinase 2 (CLK2) with an IC50 of 1.4 nM. LQ23 exhibits anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-N12625
CAS No.: 1364123-68-1
(R)-(+)-O-Demethylbuchenavianine is an inhibitor for Cyclin-dependent kinases (CDK). (R)-(+)-O-Demethylbuchenavianine inhibits CDK1, CDK5, glycogen synthase kinase-3 (GSK3), cdc2-like kinase (CLK1) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), with IC50s of 1.1, 0.95, >10, >10 and >10 μM, respectively .
loading...
    loading...
Cat. No.: HY-125201
CAS No.: 2252153-37-8
Target:  

CDK

Research Areas:  

Inflammation/Immunology

Indazole 1 is a potent CDC2-like kinase 2 (CLK2) inhibitor (IC50=12.3 nM). Indazole 1 inhibits the phosphorylation of SR proteins (e.g., SRSF1, SRSF3) and modulates alternative splicing of Wnt signaling-related genes. Indazole 1 is promising for research of osteoarthritis .
loading...
    loading...
Cat. No.: HY-168209
Target:  

Wnt CDK Apoptosis

Research Areas:  

Cancer

LBM22 is a CDC2-like kinase 2 (CLK2) inhibitor with the IC50 of 3.9 nM. LBM22 has antiproliferative activity and inhibits serine/arginine-rich (SR) protein phosphorylation. LBM22 down-regulates the expression of Wnt-related proteins and anti-apoptotic proteins and can be used for study of non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-103082R
CAS No.: 2123491-32-5
Target:  

Reference Standards CDK

Research Areas:  

Others

CLK1-IN-1 (Standard) is the analytical standard of CLK1-IN-1 (HY-103082). This product is intended for research and analytical applications. CLK1-IN-1 is a potent and selective of Cdc2-like kinase 1 (CLK1) inhibitor, with an IC50 of 2 nM.
loading...
    loading...
Cat. No.: HY-103647R
CAS No.: 443798-47-8
Research Areas:  

Cancer

K00546 (Standard) is the analytical standard of K00546 (HY-103647). This product is intended for research and analytical applications. K00546 is a potent CDK1 and CDK2 inhibitor with IC50s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. K00546 is also a potent CDC2-like kinase 1 (CLK1) and CLK3 inhibitor with IC50s of 8.9 nM and 29.2 nM, respectively .
loading...
    loading...
Cat. No.: HY-108709R
CAS No.: 1618658-88-0
Target:  

Reference Standards CDK

Research Areas:  

Cancer

CC-671 (Standard) is the analytical standard of CC-671 (HY-108709). This product is intended for research and analytical applications. CC-671 is a dual TTK protein Kinase/CDC2-like Kinase (CLK2) inhibitor with IC50s of 0.005 and 0.006 μM for TTK and CLK2, respectively.
loading...
    loading...
  • 1